In the News

137 News Items found
Alexandra Joyner, Ming Li, and Kenneth Offit
Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows.
The outside of the David H. Koch Center for Cancer Care at MSK
In the Clinic
For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue. 
Jeffrey Drebin
In a recent interview, MSK's Dr. Jeffrey Drebin addressed why it’s important for people to keep up with their routine screenings and not put off cancer treatment or surgery.
Ross Levine
The oncology community has stepped up to meet the challenges of the ongoing COVID-19 pandemic but must redouble their efforts in order to stem the potential long-term consequences of this public health crisis on the field.
MSK medical oncologist Alexander Drilon
Feature
Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Feature
MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
Investigators Lea Moukarzel, Kimberly Dessources, Britta Weigelt, and Sarah Kim in the lab.
Finding
The research focused on sclerosing stromal tumor, a rare, benign ovarian tumor that is not cancer but can be misdiagnosed as cancer.
AACR sign
Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.
scientific image of lung cancer
Scientists at MSK have developed a new nanoparticle-based approach to breaking down fibrosis in cancer and other diseases, which could make immunotherapy more effective. Learn about their findings in laboratory models.
a lab coat hangs in an MSK lab
MSK Research Highlights, July 30, 2026
New MSK research uncovers why some leukemia patients stop responding to promising new drugs; examines how bone’s hardness shapes the immune battle against metastasis; shows how a telehealth tobacco treatment program helps cancer patients quit smoking; creates the first atomic-level images of a key phosphate transporter that could inform treatment of ovarian cancer and kidney disease; finds Medicare Advantage patients with cancer receive optimal treatment at lower cost; and studies how much tissue surgeons should remove for tumor-related epilepsy.